Deepak Aatresh is the CEO and visionary behind Aditazz Inc.
His idea was to borrow and learn from integrated circuit and chip design methodologies to design and construct complex healthcare buildings. His vision led the firm to develop and design automation tools that are linked directly to advanced manufacturing processes.
Prior to Aditazz, Deepak was an Entrepreneur-in-Residence at Artiman Ventures. Deepak spent seven years at Intel Corporation as part of the Architecture and Design team of several generations of microprocessors.
Deepak has a master’s degree in Electrical and Computer Engineering from the Arizona State University and a bachelor’s degree in Electrical Engineering from Bangalore University in India. He currently holds eight patents.
Aditazz designs and delivers next-generation facilities by integrating new design, technology and manufacturing techniques. Based in Silicon Valley, the company brings together experts and innovations from the worlds of semiconductor design, applied mathematics, computer science, building architecture, systems and structural engineering, modular manufacturing and assembly, and planning and operations. It has created a new generation of tools and technologies that results in dramatic increases in building construction speed, flexibility, predictability and cost-savings—all while maintaining the highest degree of aesthetic and functional elegance.
Currently on the boards of Adama Materials, Aditazz, Auryn, CellMax Life, Guavus, Kaybus, Niron Magnetics and InvenSense. Amit Shah is peerless in creating globally renowned businesses. A successful serial entrepreneur, Amit founded two companies Zeitnet (acquired by Cabletron) and PipeLinks (acquired by Cisco) before founding Artiman Ventures. Over the years, he has led investments in companies such as Everest Design Automation (acquired by Synopsys), IKANOS (Nasdaq: IKAN), iManage (Nasdaq: IMAN), Lightwire (acquired by Cisco Systems), Netscaler (acquired by Citrix), Sierra Design Automation (acquired by Mentor Graphics), Tavant (acquired by Ameriquest).
Ajit Singh focuses on early-stage Technology and Life Science investments. He currently represents Artiman on the boards of Aditazz, CardioDx, Click Diagnostics, CORE Diagnostics, MedECube and OncoStem. A Consulting Professor in the School of Medicine at Stanford University, Ajit has two published books and five patents under his belt.